Please Wait.....
Report
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
Market Report I 2025-08-15 I 330 Pages I MarketsandMarkets
The global electrophysiology market is expected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% during the forecast period. The projected growth in the electrophysiology market is driven by technological advancements and increased research funding. The worldwide shift toward value-based care and early intervention also encourages wider adoption of diagnostic EP tools like implantable loop recorders and wearable ECG devices. Additionally, the growth of telehealth after COVID-19 has improved access to remote arrhythmia monitoring and follow-up care. Increased government investment in cardiac programs, rising investments from public-private partnerships, and ongoing integration of AI and robotic navigation systems further improve procedure efficiency and standardization. Overall, these factors are fueling strong global expansion of the electrophysiology market.
https://www.marketsandmarkets.com/Images/electrophysiology-market-Overview.webp
"On the basis of product, the electrophysiology ablation catheters commanded the largest share in the electrophysiology market in 2024."
The electrophysiology market is categorized into several segments: electrophysiology laboratory devices, electrophysiology ablation catheters, electrophysiology diagnostic catheters, EP access products, and additional device types. The expansion of the electrophysiology (EP) ablation catheter sector is propelled by multiple factors. Notably, there is an increasing global incidence of atrial fibrillation (AF) and other cardiac arrhythmias, particularly within aging demographics, which heightens the demand for effective therapeutic interventions. Additionally, innovations in catheter technologies-such as contact force sensing, irrigated-tip designs, and pulsed field ablation-are enhancing safety, accuracy, and efficacy, thereby facilitating increased adoption among electrophysiologists.
"On the basis of indication, the atrial fibrillation devices segment held the largest share in the electrophysiology market in 2024."
By product, the electrophysiology market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white (WPW) syndrome, and other indications. The expansion of the atrial fibrillation (AF) segment within the electrophysiology (EP) market is largely attributed to a convergence of demographic, lifestyle, clinical, and technological influences. The increasing global demographic of aging individuals, alongside rising rates of obesity, hypertension, diabetes, and sedentary behaviors, has led to a notable surge in AF prevalence. This growing burden of AF is driving heightened demand for EP diagnostics and therapeutic interventions. Moreover, significant advancements in EP procedural techniques, such as enhanced catheter ablation methods, state-of-the-art mapping systems, and sophisticated intracardiac imaging technologies, have markedly improved both the efficacy and safety profiles of interventions. These innovations are prompting clinicians to adopt ablation procedures earlier in the treatment continuum and with greater frequency, reflecting a paradigm shift in the management of AF.
"By region, North America accounted for the largest market share in 2024."
The electrophysiology sector in North America is experiencing robust expansion, primarily driven by the rising incidence of cardiac arrhythmias, notably atrial fibrillation. This trend correlates with an aging demographic and a high prevalence of comorbidities such as obesity, diabetes, and hypertension. Consequently, there is an escalating demand for advanced diagnostic and therapeutic electrophysiological procedures. Recent innovations-including 3D electro-anatomical mapping, enhanced radiofrequency and cryoablation technologies, and the introduction of pulsed-field ablation-have markedly improved procedural accuracy, patient safety, and clinical outcomes. These advancements are facilitating greater integration of electrophysiology practices within standard cardiology workflows.
"Asia Pacific to register the highest CAGR during the forecast period."
During the forecast period, the Asia Pacific (APAC) region is poised to experience considerable growth in the electrophysiology market. This region encompasses key markets such as India, China, Japan, Australia, South Korea, and Rest of Asia Pacific. The APAC electrophysiology market is witnessing a notable acceleration due to several interrelated factors. The escalating healthcare costs in major APAC countries-including China, India, Japan, and South Korea-are driving healthcare providers to adopt advanced medical technologies at an expedited pace. Enhanced healthcare infrastructure is facilitating this transition, allowing for greater accessibility to sophisticated electrophysiological devices. Moreover, the rising prevalence of cardiovascular diseases, attributable to demographic shifts such as aging populations, urbanization, and changing lifestyles, underscores the urgent need for effective diagnosis and treatment methodologies. Electrophysiology procedures, significantly relied upon for assessing and managing cardiac disorders, are consequently fueling demand for associated diagnostic and therapeutic devices within the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
- By Designation: C-level-27%, Director-level-18%, and Others-55%
- By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%
Key players in the electrophysiology market are Johnson & Johnson Services, Inc.(US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific Corporation (US), Japan Lifeline Co., Ltd (Japan), Stereotaxis, Inc.(US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), Teleflex Incorporated (US), Acutus Medical, Inc. (US), Merit Medical Systems (US), OSYPKA MEDICAL (Germany), Cook (US), Epmap-System (Germany), CathRx Ltd. (Australia), EP Solutions (Switzerland), CathVision (Denmark), TZ Medical, Inc. (US), APN Health, LLC (US), Lepu Medical Technology(Beijing)Co., Ltd (China), CardioFocus (US), Schwarzer Cardiotek (Germany), and Imricor (US).
Study Coverage:
The report analyzes the electrophysiology market and aims at estimating the market size and future growth potential of this market based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pressure monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers
- The report studies the electrophysiology market based on product, indication, end user, and region
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market.
- The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
- Analysis of key drivers (technological innovations for advanced, effective, and easy-to-use electrophysiological devices; high geriatric population and increased prevalence of cardiovascular diseases; rising investments, funds, and grants for cardiac surgeries and electrophysiology; increasing cardiovascular disease incidence and procedural volume), restraints (high product cost and inadequate reimbursement in developing and under-resourced healthcare settings, unfavorable healthcare reforms in US); opportunities (substantial growth opportunities in emerging economies, popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services), and challenges (global shortage of skilled and experienced personnel) influencing the growth of the electrophysiology market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the Electrophysiology market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), and Boston Scientific Corporation (US), among others.
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 33
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH APPROACH 35
2.1.1 SECONDARY DATA 35
2.1.1.1 Key secondary sources 36
2.1.1.2 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Key primary sources 37
2.1.2.2 Objectives of primary research 37
2.1.2.3 Key data from primary sources 38
2.1.2.4 Breakdown of primaries 38
2.1.2.5 Key insights from primaries 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 REVENUE SHARE ANALYSIS 40
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 42
2.2.3 TOP-DOWN APPROACH (UTILIZATION RATE AND ADOPTION PATTERN) 42
2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 43
2.3 GROWTH FORECAST 44
2.4 DATA TRIANGULATION 46
2.5 STUDY ASSUMPTIONS 47
2.6 RESEARCH IMITATIONS 47
2.6.1 SCOPE-RELATED LIMITATIONS 47
2.6.2 METHODOLOGY-RELATED LIMITATIONS 47
2.7 RISK ANALYSIS 48
3 EXECUTIVE SUMMARY 49
?
4 PREMIUM INSIGHTS 52
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 52
4.2 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND COUNTRY 53
4.3 ELECTROPHYSIOLOGY MARKET: REGIONAL MIX 53
4.4 ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54
4.5 ELECTROPHYSIOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Technological innovations for advanced, effective, and easy-to-use electrophysiological devices 56
5.2.1.1.1 Rising use of non-invasive cardiac mapping 56
5.2.1.1.2 Increasing use of improved intracardiac ablation systems 57
5.2.1.1.3 Rising use of MRI-guided ablation procedures 57
5.2.1.1.4 Increasing ultrasound guidance in electrophysiology labs 58
5.2.1.2 High geriatric population and increased prevalence of cardiovascular diseases 58
5.2.1.3 Rising investments, funds, and grants for cardiac surgeries and electrophysiology 59
5.2.1.4 Increasing cardiovascular disease incidence and procedural volume 60
5.2.2 RESTRAINTS 61
5.2.2.1 High product cost and inadequate reimbursement in developing and under-resourced healthcare settings 61
5.2.2.2 Unfavorable healthcare reforms in US 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Substantial growth opportunities in emerging economies 63
5.2.3.2 Popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services 64
5.2.4 CHALLENGES 64
5.2.4.1 Global shortage of skilled and experienced personnel 64
5.3 INDUSTRY TRENDS 65
5.3.1 INTEGRATION OF DIGITAL TECHNOLOGIES, ARTIFICAL INTELLIGENCE, AND REMOTE MONITORING IN ELECTROPHYSIOLOGY 65
5.3.2 ROBOTIC-ASSISTED ABLATION AND NAVIGATION TECHNOLOGIES FOR BETTER TRACTION IN ELECTROPHYSIOLOGY 65
5.4 TECHNOLOGY ANALYSIS 66
5.4.1 KEY TECHNOLOGIES 66
5.4.1.1 3D mapping and navigation systems 66
5.4.1.2 Cryoablation and radiofrequency ablation technologies 67
5.4.2 COMPLEMENTARY TECHNOLOGIES 67
5.4.2.1 Cardiac imaging technologies 67
5.4.2.2 Robotic navigation systems 67
5.4.3 ADJACENT TECHNOLOGIES 68
5.4.3.1 AI-enabled intravascular optical coherence tomography (OCT) 68
5.4.3.2 AI-driven view guidance in intra-cardiac echocardiography (ICE) 68
5.5 PORTER'S FIVE FORCES ANALYSIS 68
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 69
5.5.2 BARGAINING POWER OF BUYERS 70
5.5.3 BARGAINING POWER OF SUPPLIERS 70
5.5.4 THREAT OF SUBSTITUTES 70
5.5.5 THREAT OF NEW ENTRANTS 70
5.6 KEY STAKEHOLDERS & BUYING CRITERIA 71
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
5.6.2 KEY BUYING CRITERIA 72
5.7 REGULATORY ANALYSIS 72
5.7.1 REGULATORY FRAMEWORK 72
5.7.1.1 North America 73
5.7.1.1.1 US 73
5.7.1.1.2 Canada 74
5.7.1.2 Europe 74
5.7.1.3 Asia Pacific 75
5.7.1.3.1 Japan 75
5.7.1.3.2 China 76
5.7.1.3.3 India 76
5.7.1.4 Latin America 77
5.7.1.4.1 Brazil 77
5.7.1.5 Middle East & Africa 77
5.7.1.5.1 UAE 77
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.8 REIMBURSEMENT SCENARIO ANALYSIS 79
5.9 PATENT ANALYSIS 81
5.9.1 PATENT PUBLICATION TRENDS FOR ELECTROPHYSIOLOGY MARKET 81
5.9.2 LIST OF KEY PATENTS 83
5.10 TRADE ANALYSIS 84
5.10.1 IMPORT DATA FOR HS CODE 901890, 2020?2024 84
5.10.2 EXPORT DATA FOR HS CODE 901890, 2020?2024 85
5.11 PRICING ANALYSIS 85
5.11.1 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022-2024 85
5.11.2 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022-2024 86
5.12 KEY CONFERENCES & EVENTS, 2025?2026 87
5.13 UNMET NEEDS & END-USER EXPECTATIONS 88
5.14 VALUE CHAIN ANALYSIS 88
5.15 SUPPLY CHAIN ANALYSIS 90
5.16 ECOSYSTEM ANALYSIS 91
5.17 CASE STUDY ANALYSIS 92
5.17.1 JOHNSON & JOHNSON TO EXPAND CARTO SUITE AND LEVERAGE AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING 92
5.17.2 ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY 92
5.17.3 PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT 93
5.18 ADJACENT MARKET ANALYSIS 94
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 94
5.20 INVESTMENT & FUNDING SCENARIO 94
5.21 IMPACT OF AI/GEN AI ON ELECTROPHYSIOLOGY MARKET 95
5.22 IMPACT OF 2025 US TARIFF ON ELECTROPHYSIOLOGY MARKET 95
5.22.1 KEY TARIFF RATES 96
5.22.2 PRICE IMPACT ANALYSIS 97
5.22.3 IMPACT ON COUNTRY/REGION 97
5.22.3.1 North America 97
5.22.3.1.1 US 97
5.22.3.2 Europe 98
5.22.3.3 Asia Pacific 98
5.22.4 IMPACT ON END-USE INDUSTRIES 99
5.22.4.1 Hospitals & clinics 99
5.22.4.2 Ambulatory surgery centers 99
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 100
6.1 INTRODUCTION 101
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 102
6.2.1 3D MAPPING SYSTEMS 103
6.2.1.1 Development of alternative technologies to limit market growth 103
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 105
6.2.2.1 Increasing public-private funding for developing advanced novel recording systems to augment market growth 105
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 106
6.2.3.1 Cost-effectiveness and technological advancements to spur segment growth 106
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS 108
6.2.4.1 Rising lifestyle- and age-related disorders to drive adoption for cardiac disease treatment 108
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 109
6.2.5.1 High incidence of cardiovascular disorders and availability of technologically advanced equipment to boost market growth 109
?
6.2.6 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS 111
6.2.6.1 Favorable reimbursement scenario to propel market growth 111
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 113
6.3.1 CRYOABLATION CATHETERS 114
6.3.1.1 Therapeutic advantages and better clinical studies to drive market growth 114
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 116
6.3.2.1 Technologically-advanced and safer catheters to drive adoption among healthcare professionals 116
6.3.3 MICROWAVE ABLATION (MWA) CATHETERS 118
6.3.3.1 Smaller diameter antennas, faster procedure times, and larger heating zones to aid market growth 118
6.3.4 LASER ABLATION CATHETERS 119
6.3.4.1 Launch of technologically-advanced laser ablation catheters to drive adoption in healthcare settings 119
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 121
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 122
6.4.1.1 Development of technologically-advanced fixed and steerable diagnostic catheters to favor market growth 122
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 124
6.4.2.1 Advanced electrophysiology diagnostic catheters to improve patient outcomes and optimize surgical procedures 124
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 125
6.4.3.1 Availability of advanced ultrasound catheters and focus on supportive regulatory frameworks to drive segment 125
6.5 ELECTROPHYSIOLOGY ACCESS DEVICES 126
6.5.1 LAUNCH OF ADVANCED ACCESS DEVICES TO ENHANCE EFFICIENCY DURING ABLATION CATHETER MAPPING AND POSITIONING 126
6.6 OTHER ELECTROPHYSIOLOGY PRODUCTS 128
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION 129
7.1 INTRODUCTION 130
7.2 ATRIAL FIBRILLATION 130
7.2.1 DEVELOPMENT OF ADVANCED CARDIAC MAPPING SYSTEMS FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET 130
7.3 ATRIAL FLUTTER 132
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATING ATRIAL FLUTTER TO PROPEL MARKET GROWTH 132
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 134
7.4.1 INCREASING EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR TREATMENT OF AVNRT TO AID MARKET GROWTH 134
7.5 WOLFF-PARKINSON-WHITE (WPW) SYNDROME 135
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO AUGMENT MARKET GROWTH 135
7.6 OTHER INDICATIONS 137
8 ELECTROPHYSIOLOGY MARKET, BY END USER 139
8.1 INTRODUCTION 140
8.2 HOSPITALS & CARDIAC CENTERS 140
8.2.1 PRESENCE OF BETTER CATHETERIZATION AND ELECTROPHYSIOLOGY LABORATORIES IN HOSPITALS TO SUPPORT MARKET GROWTH 140
8.3 AMBULATORY SURGERY CENTERS 141
8.3.1 DEMAND FOR MINIMAL HOSPITAL STAYS AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH 141
8.4 OTHER END USERS 143
9 ELECTROPHYSIOLOGY MARKET, BY REGION 145
9.1 INTRODUCTION 146
9.2 NORTH AMERICA 147
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148
9.2.2 US 152
9.2.2.1 US to dominate North American electrophysiology market during forecast period 152
9.2.3 CANADA 156
9.2.3.1 Growing government research funding to support market growth 156
9.3 EUROPE 160
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 160
9.3.2 GERMANY 164
9.3.2.1 Rising prevalence of atrial fibrillation and associated arrhythmias to propel market growth 164
9.3.3 UK 168
9.3.3.1 High geriatric population and rise in cardiac diseases to fuel market growth 168
9.3.4 FRANCE 172
9.3.4.1 Favorable government healthcare policies and schemes to support market growth 172
9.3.5 ITALY 176
9.3.5.1 Rising incidence of cardiovascular diseases to drive adoption of electrophysiology devices 176
9.3.6 SPAIN 179
9.3.6.1 Rising number of cardiac ablation procedures to drive adoption of electrophysoiology products 179
9.3.7 REST OF EUROPE 182
9.4 ASIA PACIFIC 186
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186
9.4.2 JAPAN 191
9.4.2.1 Favorable reimbursement scenario and presence of universal healthcare policies to boost market growth 191
9.4.3 CHINA 195
9.4.3.1 Growing geriatric population and rising prevalence of cardiovascular diseases to favor market growth 195
9.4.4 INDIA 199
9.4.4.1 Favorable government healthcare initiatives to support market growth 199
9.4.5 AUSTRALIA 202
9.4.5.1 Increasing target disease burden and rising government funding to spur market growth 202
9.4.6 SOUTH KOREA 205
9.4.6.1 Supportive government initiatives to drive market 205
9.4.7 REST OF ASIA PACIFIC 209
9.5 LATIN AMERICA 212
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 212
9.5.2 BRAZIL 216
9.5.2.1 Modernization of healthcare facilities to propel market growth 216
9.5.3 MEXICO 220
9.5.3.1 Favorable investment scenario for medical device manufacturers to fuel market growth 220
9.5.4 REST OF LATIN AMERICA 223
9.6 MIDDLE EAST & AFRICA 226
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 227
9.6.2 GCC COUNTRIES 231
9.6.2.1 Kingdom of Saudi Arabia 235
9.6.2.1.1 Rising number of private hospitals and increasing government financial support to fuel market growth 235
9.6.2.2 UAE 239
9.6.2.2.1 High clinical demand, increased government investment, and technological progress to aid market growth 239
9.6.2.3 Rest of GCC Countries 242
9.6.3 REST OF MIDDLE EAST & AFRICA 245
10 COMPETITIVE LANDSCAPE 249
10.1 INTRODUCTION 249
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 249
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ELECTROPHYSIOLOGY MARKET 249
10.3 REVENUE ANALYSIS, 2020-2024 251
10.4 MARKET SHARE ANALYSIS, 2024 251
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 254
10.5.1 STARS 254
10.5.2 EMERGING LEADERS 254
10.5.3 PERVASIVE PLAYERS 254
10.5.4 PARTICIPANTS 254
?
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 256
10.5.5.1 Company footprint 256
10.5.5.2 Region footprint 256
10.5.5.3 Product footprint 257
10.5.5.4 Indication footprint 258
10.5.5.5 End-user footprint 258
10.6 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024 259
10.6.1 PROGRESSIVE COMPANIES 259
10.6.2 RESPONSIVE COMPANIES 259
10.6.3 DYNAMIC COMPANIES 259
10.6.4 STARTING BLOCKS 259
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 261
10.6.5.1 Detailed list of key startups/SMEs 261
10.6.5.2 Competitive benchmarking of startups/SMEs 261
10.7 COMPANY VALUATION & FINANCIAL METRICS 262
10.7.1 FINANCIAL METRICS 262
10.7.2 COMPANY VALUATION 262
10.8 BRAND/PRODUCT COMPARISON 263
10.9 R&D ASSESSMENT OF KEY PLAYERS 264
10.10 COMPETITIVE SCENARIO 264
10.10.1 PRODUCT LAUNCHES & APPROVALS 264
10.10.2 DEALS 265
10.10.3 OTHER DEVELOPMENTS 266
11 COMPANY PROFILES 267
11.1 KEY PLAYERS 267
11.1.1 JOHNSON & JOHNSON SERVICES, INC. 267
11.1.1.1 Business overview 267
11.1.1.2 Products offered 268
11.1.1.3 Recent developments 271
11.1.1.3.1 Product launches and approvals 271
11.1.1.3.2 Deals 272
11.1.1.4 MnM view 272
11.1.1.4.1 Right to win 272
11.1.1.4.2 Strategic choices 272
11.1.1.4.3 Weaknesses & competitive threats 272
11.1.2 ABBOTT 273
11.1.2.1 Business overview 273
11.1.2.2 Products offered 274
11.1.2.3 Recent developments 275
11.1.2.3.1 Product launches 275
11.1.2.3.2 Deals 276
11.1.2.4 MnM view 276
11.1.2.4.1 Right to win 276
11.1.2.4.2 Strategic choices 276
11.1.2.4.3 Weaknesses & competitive threats 276
11.1.3 MEDTRONIC 277
11.1.3.1 Business overview 277
11.1.3.2 Products offered 278
11.1.3.3 Recent developments 280
11.1.3.3.1 Product approvals 280
11.1.3.3.2 Deals 280
11.1.3.4 MnM view 281
11.1.3.4.1 Right to win 281
11.1.3.4.2 Strategic choices 281
11.1.3.4.3 Weaknesses & competitive threats 281
11.1.4 KONINKLIJKE PHILIPS N.V. 282
11.1.4.1 Business overview 282
11.1.4.2 Products offered 283
11.1.4.3 Recent developments 284
11.1.4.3.1 Deals 284
11.1.4.4 MnM view 284
11.1.4.4.1 Right to win 284
11.1.4.4.2 Strategic choices 284
11.1.4.4.3 Weaknesses & competitive threats 284
11.1.5 GE HEALTHCARE 285
11.1.5.1 Business overview 285
11.1.5.2 Products offered 286
11.1.5.3 Recent developments 287
11.1.5.3.1 Product approvals and enhancements 287
11.1.5.3.2 Deals 287
11.1.5.4 MnM view 288
11.1.5.4.1 Right to win 288
11.1.5.4.2 Strategic choices 288
11.1.5.4.3 Weaknesses & competitive threats 288
11.1.6 BOSTON SCIENTIFIC CORPORATION 289
11.1.6.1 Business overview 289
11.1.6.2 Products offered 290
11.1.6.3 Recent developments 293
11.1.6.3.1 Product approvals 293
11.1.6.3.2 Deals 293
?
11.1.7 JAPAN LIFELINE CO., LTD. 294
11.1.7.1 Business overview 294
11.1.7.2 Products offered 295
11.1.8 STEREOTAXIS, INC. 297
11.1.8.1 Business overview 297
11.1.8.2 Products offered 298
11.1.8.3 Recent developments 298
11.1.8.3.1 Product approvals 298
11.1.8.3.2 Deals 298
11.1.9 MICROPORT SCIENTIFIC CORPORATION 299
11.1.9.1 Business overview 299
11.1.9.2 Products offered 300
11.1.9.3 Recent developments 301
11.1.9.3.1 Product approvals 301
11.1.9.3.2 Other developments 301
11.1.10 BIOTRONIK 302
11.1.10.1 Business overview 302
11.1.10.2 Products offered 302
11.1.10.3 Recent developments 303
11.1.10.3.1 Expansions 303
11.1.11 TELEFLEX INCORPORATED 304
11.1.11.1 Business overview 304
11.1.11.2 Products offered 305
11.1.11.3 Recent developments 306
11.1.11.3.1 Deals 306
11.1.12 ACUTUS MEDICAL, INC. 307
11.1.12.1 Business overview 307
11.1.12.2 Products offered 308
11.1.12.3 Recent developments 308
11.1.12.3.1 Product approvals 308
11.1.13 MERIT MEDICAL SYSTEMS 309
11.1.13.1 Business overview 309
11.1.13.2 Products offered 310
11.1.13.3 Recent developments 311
11.1.13.3.1 Deals 311
11.1.14 OSYPKA MEDICAL 312
11.1.14.1 Business overview 312
11.1.14.2 Products offered 312
11.1.15 COOK 314
11.1.15.1 Business overview 314
11.1.15.2 Products offered 314
?
11.2 OTHER PLAYERS 315
11.2.1 EPMAP-SYSTEM 315
11.2.2 CATHRX LTD. 315
11.2.3 EP SOLUTIONS 316
11.2.4 CATHVISION 316
11.2.5 TZ MEDICAL, INC. 317
11.2.6 APN HEALTH, LLC 318
11.2.7 LEPU MEDICAL TECHNOLOGY (BEIJING) CO.,LTD. 319
11.2.8 CARDIOFOCUS 319
11.2.9 SCHWARZER CARDIOTEK 320
11.2.10 IMRICOR 320
12 APPENDIX 321
12.1 DISCUSSION GUIDE 321
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 326
12.3 CUSTOMIZATION OPTIONS 328
12.4 RELATED REPORTS 328
12.5 AUTHOR DETAILS 329
TABLE 1 ELECTROPHYSIOLOGY MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021-2024 (UNIT OF USD) 33
TABLE 3 ELECTROPHYSIOLOGY MARKET: STUDY ASSUMPTIONS 47
TABLE 4 ELECTROPHYSIOLOGY MARKET: RISK ANALYSIS 48
TABLE 5 GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023) 59
TABLE 6 MAJOR FUNDING BY KEY ORGANIZATIONS, 2023-2024 60
TABLE 7 ELECTROPHYSIOLOGY MARKET: PORTER'S FIVE FORCES 69
TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 71
TABLE 9 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY SYSTEMS 72
TABLE 10 US FDA: CLASSIFICATION OF MEDICAL DEVICES 73
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2024) 74
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY 75
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES 76
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 18 ELECTROPHYSIOLOGY MARKET: CPT CODES 80
TABLE 19 ELECTROPHYSIOLOGY MARKET: LIST OF KEY PATENTS, 2025 83
TABLE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020?2024 (USD THOUSAND) 84
TABLE 21 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020?2024 (USD THOUSAND) 85
TABLE 22 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022-2024 (USD THOUSAND) 85
TABLE 23 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS,
BY REGION, 2022-2024 (USD THOUSAND) 86
TABLE 24 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025?DECEMBER 2026 87
TABLE 25 ELECTROPHYSIOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 88
TABLE 26 CASE STUDY 1: JOHNSON & JOHNSON TO EXPAND CARTO SUITE FOR LEVERAGING AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING 92
TABLE 27 CASE STUDY 2: ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY 92
TABLE 28 CASE STUDY 3: PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT 93
TABLE 29 ELECTROPHYSIOLOGY MARKET: IMPACT OF AI/GEN AI 95
TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES 96
TABLE 31 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ELECTROPHYSIOLOGY PRODUCTS 97
TABLE 32 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 101
TABLE 33 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 102
TABLE 34 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 103
TABLE 35 3D MAPPING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 104
TABLE 36 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 106
TABLE 37 RADIOFREQUENCY (RF) ABLATION SYSTEMS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 107
TABLE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 109
TABLE 39 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 110
TABLE 40 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 112
TABLE 41 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 113
TABLE 42 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 114
TABLE 43 CRYOABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 115
TABLE 44 RADIOFREQUENCY (RF) ABLATION CATHETERS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 117
TABLE 45 COMPARISON BETWEEN RADIOFREQUENCY ABLATION AND MICROWAVE ABLATION (MWA) CATHETERS 118
TABLE 46 MICROWAVE ABLATION (MWA) CATHETERS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 119
TABLE 47 LASER ABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 120
TABLE 48 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 121
TABLE 49 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 122
TABLE 50 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 51 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 124
TABLE 52 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 53 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 127
TABLE 54 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 128
TABLE 55 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 130
TABLE 56 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY,
2023-2030 (USD MILLION) 131
TABLE 57 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY,
2023-2030 (USD MILLION) 133
TABLE 58 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 59 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE (WPW) SYNDROME, BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 60 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY COUNTRY,
2023-2030 (USD MILLION) 138
TABLE 61 ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 140
TABLE 62 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 63 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 142
TABLE 64 ELECTROPHYSIOLOGY MARKET FOR OTHER END USERS, BY COUNTRY,
2023-2030 (USD MILLION) 144
TABLE 65 ELECTROPHYSIOLOGY MARKET, BY REGION, 2023-2030 (USD MILLION) 147
TABLE 66 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 149
TABLE 67 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 149
TABLE 68 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 150
TABLE 69 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,
BY TYPE, BY VOLUME, 2023-2030 (UNITS) 150
TABLE 70 NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 151
TABLE 71 NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 151
TABLE 72 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 152
TABLE 73 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 152
TABLE 74 US: KEY MACROINDICATORS 153
TABLE 75 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 153
TABLE 76 US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 154
TABLE 77 US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 154
TABLE 78 US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 155
TABLE 79 US: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 155
TABLE 80 US: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 156
TABLE 81 CANADA: KEY MACROINDICATORS 157
TABLE 82 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 157
TABLE 83 CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 158
TABLE 84 CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 158
TABLE 85 CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 159
TABLE 86 CANADA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 159
TABLE 87 CANADA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 160
TABLE 88 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 161
TABLE 89 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 161
TABLE 90 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 162
TABLE 91 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
BY VOLUME, 2023-2030 (UNITS) 162
TABLE 92 EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 163
TABLE 93 EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 163
TABLE 94 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 164
TABLE 95 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 164
TABLE 96 GERMANY: KEY MACROINDICATORS 165
TABLE 97 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 165
TABLE 98 GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 166
TABLE 99 GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 166
TABLE 100 GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 167
TABLE 101 GERMANY: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 167
TABLE 102 GERMANY: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 168
TABLE 103 UK: KEY MACROINDICATORS 169
TABLE 104 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 169
TABLE 105 UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 170
TABLE 106 UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 170
TABLE 107 UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 171
TABLE 108 UK: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 171
TABLE 109 UK: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 172
TABLE 110 FRANCE: KEY MACROINDICATORS 172
TABLE 111 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 173
TABLE 112 FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 173
TABLE 113 FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 174
TABLE 114 FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 174
TABLE 115 FRANCE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 175
TABLE 116 FRANCE: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 175
TABLE 117 ITALY: KEY MACROINDICATORS 176
TABLE 118 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 176
TABLE 119 ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 177
TABLE 120 ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 177
TABLE 121 ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 178
TABLE 122 ITALY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 178
TABLE 123 ITALY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 179
TABLE 124 SPAIN: KEY MACROINDICATORS 179
TABLE 125 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 180
TABLE 126 SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 180
TABLE 127 SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 181
TABLE 128 SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 181
TABLE 129 SPAIN: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 182
TABLE 130 SPAIN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 182
TABLE 131 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 183
TABLE 132 REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,
BY TYPE, 2023-2030 (USD MILLION) 183
TABLE 133 REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 184
TABLE 134 REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 184
TABLE 135 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 185
TABLE 136 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 185
TABLE 137 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 188
TABLE 138 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 188
TABLE 139 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 189
TABLE 140 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
BY VOLUME, 2023-2030 (UNITS) 189
TABLE 141 ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 190
TABLE 142 ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 190
TABLE 143 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 191
TABLE 144 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 191
TABLE 145 JAPAN: KEY MACROINDICATORS 192
TABLE 146 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 192
TABLE 147 JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 193
TABLE 148 JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 193
TABLE 149 JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 194
TABLE 150 JAPAN: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 194
TABLE 151 JAPAN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 195
TABLE 152 CHINA: KEY MACROINDICATORS 195
TABLE 153 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 196
TABLE 154 CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 196
TABLE 155 CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 197
TABLE 156 CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 197
TABLE 157 CHINA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 198
TABLE 158 CHINA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 198
TABLE 159 INDIA: KEY MACROINDICATORS 199
TABLE 160 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 199
TABLE 161 INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 200
TABLE 162 INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 200
TABLE 163 INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 201
TABLE 164 INDIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 201
TABLE 165 INDIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 202
TABLE 166 AUSTRALIA: KEY MACROINDICATORS 202
TABLE 167 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 203
TABLE 168 AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 203
TABLE 169 AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 204
TABLE 170 AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 204
TABLE 171 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 205
TABLE 172 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 205
TABLE 173 SOUTH KOREA: KEY MACROINDICATORS 206
TABLE 174 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 206
TABLE 175 SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 207
TABLE 176 SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 207
TABLE 177 SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 208
TABLE 178 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 208
TABLE 179 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 209
TABLE 180 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 209
TABLE 181 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,
BY TYPE, 2023-2030 (USD MILLION) 210
TABLE 182 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 210
TABLE 183 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 211
TABLE 184 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 211
TABLE 185 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 212
TABLE 186 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 213
TABLE 187 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 213
TABLE 188 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 214
TABLE 189 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS) 214
TABLE 190 LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 215
TABLE 191 LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 215
TABLE 192 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 216
TABLE 193 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 216
TABLE 194 BRAZIL: KEY MACROINDICATORS 217
TABLE 195 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 217
TABLE 196 BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 218
TABLE 197 BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 218
TABLE 198 BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 219
TABLE 199 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 219
TABLE 200 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 220
TABLE 201 MEXICO: KEY MACROINDICATORS 220
TABLE 202 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 221
TABLE 203 MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 221
TABLE 204 MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 222
TABLE 205 MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 222
TABLE 206 MEXICO: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 223
TABLE 207 MEXICO: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 223
TABLE 208 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 224
TABLE 209 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 224
TABLE 210 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 225
TABLE 211 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 225
TABLE 212 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 226
TABLE 213 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 226
TABLE 214 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY REGION,
2023-2030 (USD MILLION) 227
TABLE 215 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 228
TABLE 216 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 228
TABLE 217 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS) 229
TABLE 218 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 229
TABLE 219 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 230
TABLE 220 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 230
TABLE 221 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 231
TABLE 222 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 232
TABLE 223 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 232
TABLE 224 GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 233
TABLE 225 GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 233
TABLE 226 GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,
BY TYPE, 2023-2030 (USD MILLION) 234
TABLE 227 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 234
TABLE 228 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 235
TABLE 229 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 236
TABLE 230 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 236
TABLE 231 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 237
TABLE 232 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 237
TABLE 233 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 238
TABLE 234 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 238
TABLE 235 UAE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 239
TABLE 236 UAE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,
2023-2030 (USD MILLION) 240
TABLE 237 UAE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 240
TABLE 238 UAE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2023-2030 (USD MILLION) 241
TABLE 239 UAE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 241
TABLE 240 UAE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 242
TABLE 241 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 243
TABLE 242 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 243
TABLE 243 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 244
TABLE 244 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 244
TABLE 245 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2023-2030 (USD MILLION) 245
TABLE 246 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER,
2023-2030 (USD MILLION) 245
TABLE 247 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 246
TABLE 248 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION) 246
TABLE 249 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 247
TABLE 250 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 247
TABLE 251 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION) 248
TABLE 252 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION) 248
TABLE 253 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET 249
TABLE 254 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 252
TABLE 255 ELECTROPHYSIOLOGY MARKET: REGION FOOTPRINT 256
TABLE 256 ELECTROPHYSIOLOGY MARKET: PRODUCT FOOTPRINT 257
TABLE 257 ELECTROPHYSIOLOGY MARKET: INDICATION FOOTPRINT 258
TABLE 258 ELECTROPHYSIOLOGY MARKET: END-USER FOOTPRINT 258
TABLE 259 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 261
TABLE 260 ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 261
TABLE 261 ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022-MAY 2025 264
TABLE 262 ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2022-MAY 2025 265
TABLE 263 ELECTROPHYSIOLOGY MARKET: OTHER DEVELOPMENTS,
JANUARY 2022-MAY 2025 266
TABLE 264 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 267
TABLE 265 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 268
TABLE 266 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025 271
TABLE 267 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022-MAY 2025 272
TABLE 268 ABBOTT: COMPANY OVERVIEW 273
TABLE 269 ABBOTT: PRODUCTS OFFERED 274
TABLE 270 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025 275
TABLE 271 ABBOTT: DEALS, JANUARY 2022-MAY 2025 276
TABLE 272 MEDTRONIC: COMPANY OVERVIEW 277
TABLE 273 MEDTRONIC: PRODUCTS OFFERED 278
TABLE 274 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022-MAY 2025 280
TABLE 275 MEDTRONIC: DEALS, JANUARY 2022-MAY 2025 280
TABLE 276 KONINKIJKE PHILIPS N.V.: COMPANY OVERVIEW 282
TABLE 277 KONINKIJKE PHILIPS N.V.: PRODUCTS OFFERED 283
TABLE 278 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-MAY 2025 284
TABLE 279 GE HEALTHCARE: COMPANY OVERVIEW 285
TABLE 280 GE HEALTHCARE: PRODUCTS OFFERED 286
TABLE 281 GE HEALTHCARE: PRODUCT APPROVALS AND ENHANCEMENTS,
JANUARY 2022-MAY 2025 287
TABLE 282 GE HEALTHCARE: DEALS, JANUARY 2022-MAY 2025 287
TABLE 283 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 289
TABLE 284 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 290
TABLE 285 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2022-MAY 2025 293
TABLE 286 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022-MAY 2025 293
TABLE 287 JAPAN LIFELINE CO., LTD.: COMPANY OVERVIEW 294
TABLE 288 JAPAN LIFELINE CO., LTD.: PRODUCTS OFFERED 295
TABLE 289 STEREOTAXIS, INC.: COMPANY OVERVIEW 297
TABLE 290 STEREOTAXIS, INC.: PRODUCTS OFFERED 298
TABLE 291 STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2025 298
TABLE 292 STEREOTAXIS, INC.: DEALS, JANUARY 2022-MAY 2025 298
TABLE 293 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 299
TABLE 294 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 300
TABLE 295 MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2022-MAY 2025 301
TABLE 296 MICROPORT SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022-MAY 2025 301
TABLE 297 BIOTRONIK: COMPANY OVERVIEW 302
TABLE 298 BIOTRONIK: PRODUCTS OFFERED 302
TABLE 299 BIOTRONIK: EXPANSIONS: JANUARY 2022-MAY 2025 303
TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW 304
TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED 305
TABLE 302 TELEFLEX INCORPORATED: DEALS, JANUARY 2022-MAY 2025 306
TABLE 303 ACUTUS MEDICAL, INC.: COMPANY OVERVIEW 307
TABLE 304 ACUTUS MEDICAL, INC.: PRODUCTS OFFERED 308
TABLE 305 ACUTUS MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2025 308
TABLE 306 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 309
TABLE 307 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 310
TABLE 308 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2022-MAY 2025 311
TABLE 309 OSYPKA MEDICAL: COMPANY OVERVIEW 312
TABLE 310 OSYPKA MEDICAL: PRODUCTS OFFERED 312
TABLE 311 COOK: COMPANY OVERVIEW 314
TABLE 312 COOK: PRODUCTS OFFERED 314
TABLE 313 EPMAP-SYSTEM: COMPANY OVERVIEW 315
TABLE 314 CATHRX LTD.: COMPANY OVERVIEW 315
TABLE 315 EP SOLUTIONS: COMPANY OVERVIEW 316
TABLE 316 CATHVISION: COMPANY OVERVIEW 316
TABLE 317 TZ MEDICAL, INC.: COMPANY OVERVIEW 317
TABLE 318 APN HEALTH, LLC: COMPANY OVERVIEW 318
TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 319
TABLE 320 CARDIOFOCUS: COMPANY OVERVIEW 319
TABLE 321 SCHWARZER CARDIOTEK: COMPANY OVERVIEW 320
TABLE 322 IMRICOR: COMPANY OVERVIEW 320
FIGURE 1 ELECTROPHYSIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE 31
FIGURE 2 ELECTROPHYSIOLOGY MARKET: YEARS CONSIDERED 33
FIGURE 3 ELECTROPHYSIOLOGY MARKET: RESEARCH DESIGN 35
FIGURE 4 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM SECONDARY SOURCES 36
FIGURE 5 ELECTROPHYSIOLOGY MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES) 37
FIGURE 6 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES 38
FIGURE 7 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 38
FIGURE 8 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION 39
FIGURE 9 ELECTROPHYSIOLOGY MARKET: INSIGHTS FROM INDUSTRY EXPERTS 39
FIGURE 10 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS) 40
FIGURE 11 MARKET REVENUE ESTIMATION OF MEDTRONIC (2024) 41
FIGURE 12 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE ANALYSIS 41
FIGURE 13 ELECTROPHYSIOLOGY MARKET: BOTTOM-UP APPROACH 42
FIGURE 14 ELECTROPHYSIOLOGY MARKET: TOP-DOWN APPROACH 42
FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ELECTROPHYSIOLOGY MARKET 44
FIGURE 16 ELECTROPHYSIOLOGY MARKET: CAGR PROJECTIONS
(SUPPLY-SIDE ANALYSIS), 2024 45
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DATA TRIANGULATION METHODOLOGY 46
FIGURE 18 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 49
FIGURE 19 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION) 50
FIGURE 20 ELECTROPHYSIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50
FIGURE 21 ELECTROPHYSIOLOGY MARKET: REGIONAL SNAPSHOT 51
FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISORDERS TO DRIVE MARKET 52
FIGURE 23 US AND ELECTROPHYSIOLOGY ABLATION CATHETERS ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024 53
FIGURE 24 ASIA PACIFIC TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 53
FIGURE 25 CHINA AND INDIA TO ACCOUNT FOR HIGHEST GROWTH RATES
FROM 2025 TO 2030 54
FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 54
FIGURE 27 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 55
FIGURE 28 ELECTROPHYSIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS 69
FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 71
FIGURE 30 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY END USERS 72
FIGURE 31 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015-JUNE 2025) 82
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015-JUNE 2025) 83
FIGURE 33 ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS 89
FIGURE 34 ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 91
FIGURE 35 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM ANALYSIS 91
FIGURE 36 ADJACENT MARKETS TO ELECTROPHYSIOLOGY MARKET 94
FIGURE 37 ELECTROPHYSIOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 94
FIGURE 38 ELECTROPHYSIOLOGY MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024 95
FIGURE 39 ELECTROPHYSIOLOGY MARKET: GEOGRAPHIC SNAPSHOT 146
FIGURE 40 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 148
FIGURE 41 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 187
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2020?2024) 251
FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY
MARKET (2024) 252
FIGURE 44 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 255
FIGURE 45 ELECTROPHYSIOLOGY MARKET: COMPANY FOOTPRINT 256
FIGURE 46 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 260
FIGURE 47 EV/EBITDA OF KEY VENDORS 262
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 262
FIGURE 49 ELECTROPHYSIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 263
FIGURE 50 ELECTROPHYSIOLOGY MARKET: R&D ASSESSMENT OF KEY PLAYERS,
2022-2024 264
FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 268
FIGURE 52 ABBOTT: COMPANY SNAPSHOT 274
FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT 278
FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 283
FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT 286
FIGURE 56 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 290
FIGURE 57 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT 295
FIGURE 58 STEREOTAXIS, INC.: COMPANY SNAPSHOT 297
FIGURE 59 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 300
FIGURE 60 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 305
FIGURE 61 ACUTUS MEDICAL, INC.: COMPANY SNAPSHOT 307
FIGURE 62 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 310
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security